查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439232

腦監測設備 - 全球市場考量、競爭狀況、市場預測 (2030)

Brain Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球腦監測設備市場規模預計2023年將達到63.1億美元，2030年將達到96.1億美元，2024-2030年預測期間複合年增長率為7.27%。腦部監測設備的需求主要是由神經系統疾病盛行率上升、產品開發技術進步、對神經退化性疾病的認識不斷提高以及腦部監測在臨床試驗中的使用增加所推動的。對微創設備的需求不斷增長以及腦監測設備治療應用的擴大預計將進一步推動腦監測設備市場的成長。

腦監測設備市場動態

根據世界衛生組織（WHO）2023年提供的數據，全球約有5,000萬人患有癲癇症，使其成為2019年全球最常見的神經系統疾病之一。大約 80% 的癲癇患者生活在低收入和中等收入國家。此外，據估計，如果診斷和治療得當，高達 70% 的癲癇患者可以無癲癇發作。

根據世界衛生組織2023年發布的數據，約有5,500萬人患有失智症，每年新增病例近1,000萬例。阿茲海默症是最常見的失智症，佔病例的 60-70%。

根據《歐洲阿茲海默症》（Alzheimer Europe，2019）的數據，到 2050 年，歐盟癡呆症患者人數預計將增至 14,298,671 人，整個歐洲地區將增至 18,846,286 人。

如上所述的神經系統疾病的增加可能對用於監測疾病進展以及監測治療方案成功或失敗的設備提出更高的要求。因此，預計在預測期內對大腦監測設備的需求將會增加。

然而，新興經濟體缺乏必要的醫療基礎設施，產品和程序的安全疑慮可能會在一定程度上限制腦監測設備市場的成長。

腦監測設備市場細分分析

在腦監測設備市場的產品類型部分中，預計腦電波設備部分在預測期內將佔據最大的市場份額。這是由於腦電圖設備在治療各種神經系統疾病的好處和應用。

腦電圖設備即時記錄大腦活動，這對於診斷神經系統疾病（包括癲癇和其他癲癇疾病）至關重要。可用於監測癲癇發作期間的患者或預測和控制癲癇發作。

腦電圖也用於睡眠障礙的研究，以識別睡眠異常（如果有）。幫助檢測睡眠障礙的存在和嚴重程度，包括失眠和其他與壓力相關的疾病。腦電圖測試期間的睡眠可用於綜合評估大腦活動。

當必須宣布患者腦死或昏迷時，腦電圖也可用作支持證據。

技術進步，例如允許長期腦電圖測試的無線腦電圖系統的推出，也有助於這些設備在醫療保健提供者中日益普及。

例如，Masimo 的 SedLine 是一款經 FDA 批准的大腦功能監測設備，可幫助臨床醫生監測麻醉下的大腦狀態。

因此，隨著腦電設備技術的不斷進步和應用範圍的不斷擴大，腦電設備在腦監測設備市場的其他產品類型中前景看好。

預計北美將主導整個大腦監測設備市場。

在所有地區中，預計北美將佔據大腦監測設備市場的最大份額。神經系統疾病盛行率的增加、優質醫療基礎設施的普及以及該地區主要市場參與者的存在預計將成為推動預測期內整體市場成長的主要影響因素。

該報告提供了全球大腦監測設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章腦監測設備市場報告簡介

第二章腦監測設備市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第三章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第四章腦監測設備市場關鍵因素分析

  • 腦監測設備市場驅動因素
    • 神經系統疾病患病率上升
    • 人們對神經退化性疾病的認識不斷增強
    • 產品開發的技術進步
    • 在臨床試驗中更多地使用腦監測
  • 腦監測設備市場限制與挑戰
    • 新興經濟體缺乏先進的衛生基礎設施
    • 有關產品或程序的安全問題
  • 腦監測設備市場機會
    • 對非侵入性腦監測設備的需求不斷增長
    • 提高產品安全性

第五章腦監測設備市場波特五力分析

第六章腦監測設備市場佈局

  • 按產品類型
    • 腦電圖 (EEG) 設備
    • 腦磁圖 (MEG) 設備
    • 肌電圖 (EMG) 設備
    • 經顱多普勒
    • 顱內壓監測裝置
    • 其他
  • 按設備類型
    • 侵入性的
    • 非侵入性
  • 按用途
    • 癲癇
    • 帕金森病
    • 阿爾茨海默氏病
    • 中風
  • 按最終用戶
    • 醫院
    • 診斷中心
  • 按地區
    • 北美腦監測設備市場（2021-2030）
    • 歐洲腦監測設備市場（2021-2030）
    • 亞太地區腦監測設備市場（2021-2030）
    • 其他地區腦監測設備市場（2021-2030）

第七章 腦監測設備公司及產品簡介

  • Medtronic
  • Nonin
  • Raumedic AG
  • Edwards Lifesciences Corporation
  • BrainScope Company Inc
  • NIHON KOHDEN CORPORATION
  • Neurosoft
  • Advanced Brain Monitoring Inc
  • Rimed
  • Masimo
  • NeuroWave Systems Inc
  • Compumedics Limited
  • Spiegelberg GmbH & Co. KG
  • NOVASIGNAL CORPORATION

第8章 KOL觀點

第9章 專案方法

第十章 DelveInsight服務內容

第 11 章關於 DelveInsight

第十二章 免責聲明與聯絡我們

Product Code: DIMDCL0017

Brain Monitoring Devices Market By Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive and Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of neurological diseases and rising application of brain monitoring in clinical trials

Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030. The demand for brain monitoring devices is primarily being boosted by the rising prevalence of neurological diseases, technological advancement in product development, rising awareness about neurodegenerative diseases, and increasing applications of brain monitoring in clinical trials. The growing demand for minimally invasive devices and the expanded therapeutic applications of brain monitoring devices are further expected to boost the brain monitoring devices market growth.

Brain Monitoring Devices Market Dynamics:

According to the data provided by the World Health Organization (WHO) 2023, approximately 50 million people across the globe were suffering from epilepsy, making it one of the most common neurological diseases globally in 2019. About 80% of people with epilepsy live in low- and middle-income countries. Furthermore, it is predicted that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.

As per the data provided by WHO 2023, about 55 million people are living with dementia, and there are nearly 10 million new cases every year. Alzheimer's disease is the commonest form of dementia and contributes to 60-70% of cases.

According to Alzheimer Europe 2019, it has been estimated that by 2050 the number of people with dementia will increase to 14,298,671 in the EU and 18,846,286 in the wider European region.

The rising number of neurological diseases such as those mentioned above would result in the greater requirement for devices used in monitoring disease progression along with the monitoring of treatment regimens being successful or not. Therefore, the demand for brain monitoring devices is expected to witness an increase in the forecast period.

However, the non-availability of the required healthcare infrastructure in developing economies, and safety concerns regarding products and procedures may prove to be certain restraints to the brain monitoring devices market growth.

Brain Monitoring Devices Market Segment Analysis:

Brain Monitoring Devices by Product Type (Electroencephalography (EEG) Devices, Magnetoencephalography (MEG) Devices, Electromyography (EMG) Devices, Transcranial Doppler, Intracranial Pressure Monitoring Devices, and Others), Device Type (Invasive And Non Invasive), Application (Epilepsy, Parkinson's Disease, Alzheimer's Disease, Strokes, and Others), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the brain monitoring devices market, the electroencephalography (EEG) devices segment is expected to account for the largest market share during the forecast period. This can be attributed to the advantages and applications associated with EEG devices in the treatment of various neurological diseases.

EEG devices are crucial for the diagnosis of neurological conditions including epilepsy and other seizure disorders as they record brain activity in real time. It assists in the monitoring of patients between epileptic episodes, or to predict and control seizures.

EEG devices are also employed in studying sleep disorders for the identification of any sleep abnormality if present. They help detect the presence and severity of sleep disorders including insomnia and other stress-related disorders. Sleep during an EEG allows for a comprehensive evaluation of brain activity.

EEG studies are also used as supportive evidence in cases where a patient has to be declared brain dead or is in a coma.

Technological advancements such as the launch of wireless EEG systems where long-term EEG studies can be carried out have also contributed to the rising popularity of these devices among healthcare providers.

For example, SedLine by Masimo is FDA cleared brain function monitoring device that helps clinicians monitor the state of the brain under anesthesia, with bilateral acquisition and processing of four leads of electroencephalogram (EEG) signals.

Therefore, the constant technological advancements coupled with the extended application of EEG devices present a positive outlook for EEG devices among other product types in the brain monitoring devices market.

North America is expected to dominate the overall Brain Monitoring Devices Market:

Among all the regions, North America is expected to account for the largest share of the brain monitoring devices market. The growing prevalence of neurological diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

As per the data provided by Parkinson's Foundation 2022, about one million people are living with Parkinson's disease (PD) in the US in 2021. This is expected to rise to 1.2 million by 2030. It has been estimated that approximately 60,000 Americans are diagnosed with PD each year. Near bout four percent of people with PD are diagnosed before age 50.

According to the Centers for Disease Prevention and Control (CDC) 2020, there were about 61,000 traumatic brain injury (TBI)-related deaths in the United States in 2019. These statistics point toward the rising number of cases associated with neurological indications.

Considering the presence of a large patient pool in the US coupled with increasing product development activities, the market for brain monitoring devices looks promising in the United States.

For example in August 2020, Masimo received FDA clearance for O3® Regional Oximetry for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult patients.

Furthermore, the presence of key players such as Edward Lifesciences Corporation and Medtronic among others and their initiatives to raise awareness on neurological disorders and their management could increase the adoption of brain monitoring devices in the US thus bolstering the market.

Brain Monitoring Devices Market Key Players:

Some of the key market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.

Recent Developmental Activities in Brain Monitoring Devices Market:

In April 2021, Integra LifeSciences Corporation received a 510(k) clearance by the US Food and Drug Administration for CereLink ICP Monitor. This device is intended to be used as an interface between standard physiological pressure monitoring systems and compatible strain-gauge-type pressure transducers.

In March 2021, Brain Scientific Inc received a 510(k) clearance for its next-generation NeuroCap(TM) device. This device is an advanced Electroencephalogram (EEG) electrode array that is employed in routine clinical and research settings to obtain rapid EEGs where STAT EEG recordings are desired.

In February 2020, Compumedics Limited received a 510k clearance from the US FDA for their Orion LifeSpan MEG. This device is equipped to non-invasively measure the magnetoencephalographic (MEG) signals with the option to measure electroencephalographic (EEG) signals as well which are produced by electrically active tissue of the brain.

Key Takeaways from the Brain Monitoring Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the brain monitoring devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Brain Monitoring Devices Market.

Various opportunities available for the other competitor in the Brain Monitoring Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current brain monitoring devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for brain monitoring devices market growth in the coming future?

Target Audience who can be benefited from this Brain Monitoring Devices Market Report Study

Brain Monitoring Devices products providers

Research organizations and consulting companies

Brain Monitoring Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in brain monitoring devices

Various End-users who want to know more about the Brain Monitoring Devices market and the latest technological developments in the Brain Monitoring Devices market.

Frequently Asked Questions for Brain Monitoring Devices Market:

What is a Brain Monitoring Device?

A brain monitoring device helps in the assessment and monitoring of brain function wherein they help in the monitoring of different parameters. EEG, MEG, and functional MRI are a few common brain monitoring devices available in the brain monitoring products market among others.

What is the market for Global Brain Monitoring Devices?

Global Brain Monitoring Devices Market was valued at USD 6.31 billion in 2023, growing at a CAGR of 7.27% during the forecast period from 2024 to 2030, to reach USD 9.61 billion by 2030.

What are the drivers for Global Brain Monitoring Devices Market?

The major drivers of the global brain monitoring devices market growth are the rising prevalence of neurological diseases, growing awareness about neurodegenerative diseases, and the expansion of brain monitoring devices to therapeutic applications among other contributing factors.

What are the key players operating in Global Brain Monitoring Devices Market?

Some of the important market players operating in the brain monitoring devices market include NONIN, Raumedic AG, Masimo, Natus Medical Incorporated, Edwards Lifesciences Corporation, Neurosoft, Advanced Brain Monitoring, Inc, BrainScope Company Inc, Medtronic, NIHON KOHDEN CORPORATION, NeuroWave Systems Inc, Compumedics Limited, Spiegelberg GmbH & Co. KG, Rimed, NOVASIGNAL CORPORATION, and others.

What regions have the highest share in the Brain Monitoring Devices market?

North America is expected to dominate the overall Brain Monitoring Devices market during the forecast period, 2024 to 2030. The high revenue domination across regions by North America can be attributed to the prevalence of neurodegenerative diseases, access to better healthcare infrastructure in the region majorly in the US and Canada along with the presence of major market players in the region. These are expected to be the major influencing factors in driving the overall growth of the brain monitoring devices market over the forecast period.

Table of Contents

1. Brain Monitoring Devices Market Report Introduction

2. Brain Monitoring Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at a Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Brain Monitoring Devices Market Key Factors Analysis

  • 4.1. Brain Monitoring Devices Market Drivers
    • 4.1.1. Rising Prevalence of Neurological Diseases
    • 4.1.2. Rising Awareness Regarding Neurodegenerative Diseases
    • 4.1.3. Technological Advancements in Product Development
    • 4.1.4. Increasing Application of Brain Monitoring in Clinical Trials
  • 4.2. Brain Monitoring Devices Market Restraints and Challenges
    • 4.2.1. Lack of Advanced Healthcare Infrastructure in Developing Economies
    • 4.2.2. Product and Procedure related Safety Concerns
  • 4.3. Brain Monitoring Devices Market Opportunities
    • 4.3.1. Growing Demand for Non-Invasive Brain Monitoring Devices
    • 4.3.2. Improving Product Safety

5. Brain Monitoring Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Brain Monitoring Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Electroencephalography (EEG) Devices
    • 6.1.2. Magnetoencephalography (MEG) Devices
    • 6.1.3. Electromyography (EMG) Devices
    • 6.1.4. Transcranial Doppler
    • 6.1.5. Intracranial Pressure Monitoring Devices
    • 6.1.6. Others
  • 6.2. By Device Type
    • 6.2.1. Invasive
    • 6.2.2. Non-Invasive
  • 6.3. By Application
    • 6.3.1. Epilepsy
    • 6.3.2. Parkinson's Disease
    • 6.3.3. Alzheimer's Disease
    • 6.3.4. Strokes
    • 6.3.5. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Brain Monitoring Devices Market in USD million(2021-2030)
      • 6.5.1.1. United States Brain Monitoring Devices Market in USD million(2021-2030)
      • 6.5.1.2. Canada Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.1.3. Mexico Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.2. Europe Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.1. France Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.2. Germany Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.4. Italy Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.5. Spain Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.1. China Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.2. Japan Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.3. India Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.4. Australia Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.5. South Korea Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia-Pacific Brain Monitoring Devices Market in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.1. Middle East Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.2. Africa Brain Monitoring Devices Market in USD million (2021-2030)
      • 6.5.4.3. South America Brain Monitoring Devices Market in USD million (2021-2030)

7. Brain Monitoring Devices Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nonin
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Raumedic AG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4 Natus Medical Incorporated7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Edwards Lifesciences Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. BrainScope Company Inc
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. NIHON KOHDEN CORPORATION
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Neurosoft
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Advanced Brain Monitoring Inc
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Rimed
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Masimo
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. NeuroWave Systems Inc
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Compumedics Limited
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Spiegelberg GmbH & Co. KG
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. NOVASIGNAL CORPORATION
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Brain Monitoring Devices Market in Global (2021-2030)
  • Table 3: Brain Monitoring Devices Market in Global by Product Type (2021-2030)
  • Table 4: Brain Monitoring Devices Market in Global by Device Type (2021-2030)
  • Table 5: Brain Monitoring Devices Market in Global by Application (2021-2030)
  • Table 6: Brain Monitoring Devices Market in Global by End-User (2021-2030)
  • Table 7: Brain Monitoring Devices Market in Global by Geography (2021-2030)
  • Table 8: Brain Monitoring Devices Market in North America (2021-2030)
  • Table 9: Brain Monitoring Devices Market in the US (2021-2030)
  • Table 10: Brain Monitoring Devices Market in Canada (2021-2030)
  • Table 11: Brain Monitoring Devices Market in Mexico (2021-2030)
  • Table 12: Brain Monitoring Devices Market in Europe (2021-2030)
  • Table 13: Brain Monitoring Devices Market in France (2021-2030)
  • Table 14: Brain Monitoring Devices Market in Germany (2021-2030)
  • Table 15: Brain Monitoring Devices Market in the United Kingdom (2021-2030)
  • Table 16: Brain Monitoring Devices Market in Italy (2021-2030)
  • Table 17: Brain Monitoring Devices Market in Spain (2021-2030)
  • Table 18: Brain Monitoring Devices Market in Rest of Europe (2021-2030)
  • Table 19: Brain Monitoring Devices Market in Asia-Pacific (2021-2030)
  • Table 20: Brain Monitoring Devices Market in China (2021-2030)
  • Table 21: Brain Monitoring Devices Market in Japan (2021-2030)
  • Table 22: Brain Monitoring Devices Market in India (2021-2030)
  • Table 23: Brain Monitoring Devices Market in Australia (2021-2030)
  • Table 24: Brain Monitoring Devices Market in South Korea (2021-2030)
  • Table 25: Brain Monitoring Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Brain Monitoring Devices Market in the Rest of the World (2021-2030)
  • Table 27: Brain Monitoring Devices Market in the Middle East (2021-2030)
  • Table 28: Brain Monitoring Devices Market in Africa (2021-2030)
  • Table 29: Brain Monitoring Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Brain Monitoring Devices Market in Global (2021-2030)
  • Figure 3: Brain Monitoring Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Brain Monitoring Devices Market in Global by Device Type (2021-2030)
  • Figure 5: Brain Monitoring Devices Market in Global by Application (2021-2030)
  • Figure 6: Brain Monitoring Devices Market in Global by End-User (2021-2030)
  • Figure 7: Brain Monitoring Devices Market in Global by Geography (2021-2030)
  • Figure 8: Brain Monitoring Devices Market in North America (2021-2030)
  • Figure 9: Brain Monitoring Devices Market in the US (2021-2030)
  • Figure 10: Brain Monitoring Devices Market in Canada (2021-2030)
  • Figure 11: Brain Monitoring Devices Market in Mexico (2021-2030)
  • Figure 12: Brain Monitoring Devices Market in Europe (2021-2030)
  • Figure 13: Brain Monitoring Devices Market in France (2021-2030)
  • Figure 14: Brain Monitoring Devices Market in Germany (2021-2030)
  • Figure 15: Brain Monitoring Devices Market in the United Kingdom (2021-2030)
  • Figure 16: Brain Monitoring Devices Market in Italy (2021-2030)
  • Figure 17: Brain Monitoring Devices Market in Spain (2021-2030)
  • Figure 18: Brain Monitoring Devices Market in the Rest of Europe (2021-2030)
  • Figure 19: Brain Monitoring Devices Market in Asia-Pacific (2021-2030)
  • Figure 20: Brain Monitoring Devices Market in China (2021-2030)
  • Figure 21: Brain Monitoring Devices Market in Japan (2021-2030)
  • Figure 22: Brain Monitoring Devices Market in India (2021-2030)
  • Figure 23: Brain Monitoring Devices Market in Australia (2021-2030)
  • Figure 24: Brain Monitoring Devices Market in South Korea (2021-2030)
  • Figure 25: Brain Monitoring Devices Market in the Rest of Asia-Pacific (2021-2030)
  • Figure 26: Brain Monitoring Devices Market in the Rest of the World (2021-2030)
  • Figure 27: Brain Monitoring Devices Market in the Middle East (2021-2030)
  • Figure 28: Brain Monitoring Devices Market in Africa (2021-2030)
  • Figure 29: Brain Monitoring Devices Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis